Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 4/2008

01-10-2008 | Conference Paper

Things are Looking up Since We Started Listening to Patients

Trends in the Application of Conjoint Analysis in Health 1982–2007

Authors: John F.P. Bridges, Elizabeth T. Kinter, Lillian Kidane, Rebekah R. Heinzen, Colleen McCormick

Published in: The Patient - Patient-Centered Outcomes Research | Issue 4/2008

Login to get access

Abstract

Clinical and healthcare decision makers have repeatedly endorsed patient-centered care as a goal of the health system. However, traditional methods of evaluation reinforce societal views, and research focusing on views of patients is often referred to as ‘soft science.’ Conjoint analysis presents a scientifically rigorous research tool that can be used to understand patient preferences and inform decision making. This paper documents applications of conjoint analysis in medicine and systematically reviews this literature in order to identify publication trends and the range of topics to which conjoint analysis has been applied. In addition, we document important methodological aspects such as sample size, experimental design, and method of analysis.
Publications were identified through a MEDLINE search using multiple search terms for identification. We classified each article into one of three categories: clinical applications (n = 122); methodological contributions (n = 56); and health system applications (n = 47). Articles that did not use or adequately discuss conjoint analysis methods (n = 164) were discarded. We identified a near exponential increase in the application of conjoint analyses over the last 10 years of the study period (1997–2007). Over this period, the proportion of applications on clinical topics increased from 40% of articles published in MEDLINE from 1998 to 2002, to 64% of articles published from 2003 to 2007 (p = 0.002).
The average sample size among articles focusing on health system applications (n = 556) was significantly higher than clinical applications (n = 277) [p = 0.001], although this 2-fold difference was primarily due to a number of outliers reporting sample sizes in the thousands. The vast majority of papers claimed to use orthogonal factorial designs, although over a quarter of papers did not report their design properties. In terms of types of analysis, logistic regression was favored among clinical applications (28%), while probit was most commonly used among health systems applications (38%). However, 25% of clinical applications and 33% of health systems articles failed to report what regression methods were used. We used the International Classification of Diseases — version 9 (ICD-9) coding system to categorize clinical applications, with approximately 26% of publications focusing on neoplasm. Program planning and evaluation applications accounted for 22% of the health system articles.
While interest in conjoint analysis in health is likely to continue, better guidelines for conducting and reporting conjoint analyses are needed.
Appendix
Available only for authorised users
Footnotes
1
Main effects refers to a model that is not powered to detect interactions among variables (i.e. different attributes) — it assumes that all attributes are independent of each other.
 
2
Fractional factorial designs take a subset of all the possible attribute combinations in order to determine what question groupings must be asked/presented. An orthogonal array literally means ‘independent’. It is the array that contains all the attribute level pairings, so that the relationship is orthogonal (i.e. only main effects are being estimated).
 
3
Adaptive conjoint analysis is a method of conjoint analysis that utilizes computer-administered interviews that customize each question for the individual respondent. Responses are analyzed as the interview progresses and each subsequent interview question presented to the respondent is customized for that individual so that each question should reveal the most information in the shortest amount of time.
 
Literature
1.
go back to reference Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 2000 Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 2000
2.
go back to reference Agency for Healthcare Research and Quality. National healthcare quality report [report no.: 07-0013]. Rockville (MD): Agency for Healthcare Research and Quality, 2006 Agency for Healthcare Research and Quality. National healthcare quality report [report no.: 07-0013]. Rockville (MD): Agency for Healthcare Research and Quality, 2006
3.
go back to reference Krumholz H, Peterson E, Ayanian J, et al. Report of the National Heart, Lung and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005; 111: 3158–66PubMedCrossRef Krumholz H, Peterson E, Ayanian J, et al. Report of the National Heart, Lung and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005; 111: 3158–66PubMedCrossRef
4.
go back to reference Bridges J. What can economics add to health technology assessment? Please not another cost-effectiveness analysis! Exp Rev Pharmacoeconomics Outcomes Res 2006; 6(1): 19–24CrossRef Bridges J. What can economics add to health technology assessment? Please not another cost-effectiveness analysis! Exp Rev Pharmacoeconomics Outcomes Res 2006; 6(1): 19–24CrossRef
5.
go back to reference Bridges J, Jones C. Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis. Pharmacoeconomics 2006; 24(S2): 101–9PubMed Bridges J, Jones C. Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis. Pharmacoeconomics 2006; 24(S2): 101–9PubMed
6.
go back to reference US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims: draft guidance. February 2006 [online]. Available from URL: http://www.fda.gov/Cder/guidance/5460dft.pdf [Accessed 2008 Jan 28] US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims: draft guidance. February 2006 [online]. Available from URL: http://​www.​fda.​gov/​Cder/​guidance/​5460dft.​pdf [Accessed 2008 Jan 28]
7.
go back to reference NHS Executive. Patient and public involvement in the new NHS. Leeds: Department of Health, 1999 NHS Executive. Patient and public involvement in the new NHS. Leeds: Department of Health, 1999
8.
go back to reference Vogt F, Schwappach DL, Bridges JF. Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. Pharmacoeconomics 2006; 24(5): 419–23PubMedCrossRef Vogt F, Schwappach DL, Bridges JF. Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare. Pharmacoeconomics 2006; 24(5): 419–23PubMedCrossRef
9.
go back to reference Bridges JF, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care 2007 Winter; 23(1): 30–5PubMedCrossRef Bridges JF, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care 2007 Winter; 23(1): 30–5PubMedCrossRef
10.
go back to reference Bridges JF. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy 2003; 2(4): 213–24PubMed Bridges JF. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy 2003; 2(4): 213–24PubMed
11.
go back to reference Green P, Rao V. Conjoint measurement for quantifying judgmental data. J Mark Res 1971; 8: 355–63CrossRef Green P, Rao V. Conjoint measurement for quantifying judgmental data. J Mark Res 1971; 8: 355–63CrossRef
12.
go back to reference Luce R, Tukey J. Simulataneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1964; 1: 1–27CrossRef Luce R, Tukey J. Simulataneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1964; 1: 1–27CrossRef
13.
go back to reference Gustafsson A, Herrmann A, Huber F. Conjoint analysis as an instrument of market research practice. In: Gustafsson A, Herrmann A, Huber F, editors. Conjoint measurement: methods and applications. Berlin: Springer, 2003: 3–30CrossRef Gustafsson A, Herrmann A, Huber F. Conjoint analysis as an instrument of market research practice. In: Gustafsson A, Herrmann A, Huber F, editors. Conjoint measurement: methods and applications. Berlin: Springer, 2003: 3–30CrossRef
14.
go back to reference Green D. Estimating daily vehicle usage distributions and the implications for limited-range vehicles. Transp Res 1985; 19B(4): 347–58CrossRef Green D. Estimating daily vehicle usage distributions and the implications for limited-range vehicles. Transp Res 1985; 19B(4): 347–58CrossRef
15.
go back to reference Segal R. Forecasting the market for electric vehicles in California using conjoint analysis. Energy J 1995; 16(6): 89–112 Segal R. Forecasting the market for electric vehicles in California using conjoint analysis. Energy J 1995; 16(6): 89–112
16.
go back to reference Cattin P, Wittink D. Commencai use of conjoint analysis: a survey. J Mark 1982; 46: 44–53CrossRef Cattin P, Wittink D. Commencai use of conjoint analysis: a survey. J Mark 1982; 46: 44–53CrossRef
17.
go back to reference Wittink D, Cattin P. Commercial use of conjoint analysis: an update. J Mark 1989; 53: 91–6CrossRef Wittink D, Cattin P. Commercial use of conjoint analysis: an update. J Mark 1989; 53: 91–6CrossRef
18.
go back to reference Kroes EP, Sheldon RJ. Stated preference methods: an introduction. JTEP 1988; 22(1): 11–25 Kroes EP, Sheldon RJ. Stated preference methods: an introduction. JTEP 1988; 22(1): 11–25
19.
go back to reference Fowkes T, Wardman M. The design of stated preference travel choice experiments, with special reference to inter-personal taste variations. JTEP 1988; 22(1): 27–44 Fowkes T, Wardman M. The design of stated preference travel choice experiments, with special reference to inter-personal taste variations. JTEP 1988; 22(1): 27–44
20.
go back to reference Hensher DA, Barnard PO, Truong TP. The role of stated preference methods in studies of travel choice. JTEP 1988; 22(1): 45–58 Hensher DA, Barnard PO, Truong TP. The role of stated preference methods in studies of travel choice. JTEP 1988; 22(1): 45–58
21.
go back to reference Bates J. Econometric issues in stated preference analysis. JTEP 1988; 22(1): 59–69 Bates J. Econometric issues in stated preference analysis. JTEP 1988; 22(1): 59–69
22.
go back to reference Wardman M. A comparison of revealed preference and stated preference models of travel behaviour. JTEP 1988; 22(1): 71–91 Wardman M. A comparison of revealed preference and stated preference models of travel behaviour. JTEP 1988; 22(1): 71–91
23.
go back to reference Louviere JJ. Conjoint analysis modelling of stated preferences: a review of theory, methods, recent developments and external validity. JTEP 1988; 22(1): 93–119 Louviere JJ. Conjoint analysis modelling of stated preferences: a review of theory, methods, recent developments and external validity. JTEP 1988; 22(1): 93–119
24.
go back to reference Bradley M. Realism and adaptation in designing hypothetical travel choice concepts. JTEP 1988; 22(1): 121–37 Bradley M. Realism and adaptation in designing hypothetical travel choice concepts. JTEP 1988; 22(1): 121–37
25.
go back to reference Rae D. Visibility impairment at Mesa Verde National Park: an analysis of benefits and costs of controlling emissions in the Four Corners area. Boston (MA): Electric Power Research Institute, 1981 Rae D. Visibility impairment at Mesa Verde National Park: an analysis of benefits and costs of controlling emissions in the Four Corners area. Boston (MA): Electric Power Research Institute, 1981
26.
go back to reference Rae D. Benefits of improving visibility at Great Smoky National Park [draft]. Boston (MA): Electric Power Research Institute, 1981 Rae D. Benefits of improving visibility at Great Smoky National Park [draft]. Boston (MA): Electric Power Research Institute, 1981
27.
go back to reference Pascoe G. Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann 1983; 6: 185–210PubMedCrossRef Pascoe G. Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann 1983; 6: 185–210PubMedCrossRef
28.
go back to reference Louviere J. Conjoint analysis modeling of stated preferences. J Transport Econ Pol 1988; 22(1): 93–119 Louviere J. Conjoint analysis modeling of stated preferences. J Transport Econ Pol 1988; 22(1): 93–119
29.
go back to reference Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future reflections. Health Econ Health Policy 2003; 2(1): 55–64 Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future reflections. Health Econ Health Policy 2003; 2(1): 55–64
30.
go back to reference Ryan M, Bate A, Eastmond C, et al. Use of discrete choice experiments to elicit preferences. Qual Saf Health Care 2001 Sep; 10Suppl. 1: i55–60CrossRef Ryan M, Bate A, Eastmond C, et al. Use of discrete choice experiments to elicit preferences. Qual Saf Health Care 2001 Sep; 10Suppl. 1: i55–60CrossRef
31.
go back to reference Lancaster K. A new approach to consumer theory. J Polit Econ 1966; 74: 132–57CrossRef Lancaster K. A new approach to consumer theory. J Polit Econ 1966; 74: 132–57CrossRef
32.
go back to reference Bingham MF, Johnson FR, Miller D. Modeling choice behavior for new pharmaceutical products. Value Health 2001 Jan–Feb; 4(1): 32–44PubMedCrossRef Bingham MF, Johnson FR, Miller D. Modeling choice behavior for new pharmaceutical products. Value Health 2001 Jan–Feb; 4(1): 32–44PubMedCrossRef
33.
go back to reference Ratcliffe J. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution? Int J Technol Assess Health Care 2000; 16(1): 270–5PubMedCrossRef Ratcliffe J. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution? Int J Technol Assess Health Care 2000; 16(1): 270–5PubMedCrossRef
34.
go back to reference Adamowicz J, Williams M. Combining revealed preference and stated preference methods for valuing environmental amenities. J Environ Econ Manage 1994; 6(6): 271–92CrossRef Adamowicz J, Williams M. Combining revealed preference and stated preference methods for valuing environmental amenities. J Environ Econ Manage 1994; 6(6): 271–92CrossRef
35.
go back to reference Hedayat A, Sloane J, Stufken J. Orthogonal arrays. New York: Springer-Verlag, 1999CrossRef Hedayat A, Sloane J, Stufken J. Orthogonal arrays. New York: Springer-Verlag, 1999CrossRef
36.
go back to reference Louviere J, Hensher D, Swait J. Stated choice methods: analysis and application. Cambridge (UK): Cambridge University Press, 2000CrossRef Louviere J, Hensher D, Swait J. Stated choice methods: analysis and application. Cambridge (UK): Cambridge University Press, 2000CrossRef
37.
go back to reference Rose J, Bliemer M. Designing stated choice experiments: the state of the art. 1 1th International Conference on Travel Behaviour Research; 2006 Aug 16–20; Kyoto Rose J, Bliemer M. Designing stated choice experiments: the state of the art. 1 1th International Conference on Travel Behaviour Research; 2006 Aug 16–20; Kyoto
38.
go back to reference Kuhfeld W, Tobias R, Garratt M. Efficient experimental design with marketing research applications. J Mark Res 1994; 11: 545–57CrossRef Kuhfeld W, Tobias R, Garratt M. Efficient experimental design with marketing research applications. J Mark Res 1994; 11: 545–57CrossRef
39.
go back to reference Orme B. Sample size issues and conjoint analysis: getting started with conjoint analysis. Strategies for product design and pricing research. Madison (WI): Research Publishers LLC, 1998 Orme B. Sample size issues and conjoint analysis: getting started with conjoint analysis. Strategies for product design and pricing research. Madison (WI): Research Publishers LLC, 1998
40.
go back to reference Train K. Discrete choice methods with simulation. Cambridge (UK): Cambridge University Press, 2003CrossRef Train K. Discrete choice methods with simulation. Cambridge (UK): Cambridge University Press, 2003CrossRef
41.
go back to reference Ryan M, Gerard K. Using discrete choice experiments in health economics: moving forward. In: Scott A, Mayndard A, Elliot R, editors. Advances in health economics. Hoboken (NJ): John Wiley and Sons, Ltd, 2003 Ryan M, Gerard K. Using discrete choice experiments in health economics: moving forward. In: Scott A, Mayndard A, Elliot R, editors. Advances in health economics. Hoboken (NJ): John Wiley and Sons, Ltd, 2003
42.
go back to reference Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002 Dec; 37(6): 1681–705PubMedCrossRef Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002 Dec; 37(6): 1681–705PubMedCrossRef
43.
go back to reference Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000 Jun 3; 320(7248): 1530–3PubMedCrossRef Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000 Jun 3; 320(7248): 1530–3PubMedCrossRef
44.
go back to reference Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5(5): 1–186PubMed Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5(5): 1–186PubMed
45.
go back to reference Viney R, Lancsar E, Louviere J. Discrete choice experiments to measure consumer preferences for health and healthcare. Pharmacoeconomics Outcomes Res 2002; 2(4): 89–101 Viney R, Lancsar E, Louviere J. Discrete choice experiments to measure consumer preferences for health and healthcare. Pharmacoeconomics Outcomes Res 2002; 2(4): 89–101
46.
go back to reference Bridges J, Onukwugha E, Johnson F, et al. Patient preference methods: a patient centered evaluation paradigm. ISPOR Connections 2007; 13(6): 4–7 Bridges J, Onukwugha E, Johnson F, et al. Patient preference methods: a patient centered evaluation paradigm. ISPOR Connections 2007; 13(6): 4–7
47.
go back to reference Lee J, Bridges J, Shockney L. Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer? Exp Rev Pharmacoeconomics Outcomes Res 2008 Feb; 8(1): 73–9CrossRef Lee J, Bridges J, Shockney L. Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer? Exp Rev Pharmacoeconomics Outcomes Res 2008 Feb; 8(1): 73–9CrossRef
Metadata
Title
Things are Looking up Since We Started Listening to Patients
Trends in the Application of Conjoint Analysis in Health 1982–2007
Authors
John F.P. Bridges
Elizabeth T. Kinter
Lillian Kidane
Rebekah R. Heinzen
Colleen McCormick
Publication date
01-10-2008
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 4/2008
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.2165/1312067-200801040-00009

Other articles of this Issue 4/2008

The Patient - Patient-Centered Outcomes Research 4/2008 Go to the issue

Pioneer Profile

Andrew Lloyd

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.